Profund Advisors’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Profund Advisors’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-31,335	Closed	-$1.1M	–	1194
2024 Q1	$1.1M	Buy	31,335 +14,211	+83%	+$518K	0.04%	333
2023 Q4	$651K	Sell	17,124 -2,622	-13%	-$56.2K	0.03%	437
2023 Q3	$362K	Sell	19,746 -4,409	-18%	-$92.3K	0.02%	570
2023 Q2	$627K	Sell	24,155 -4,644	-16%	-$108K	0.03%	434
2023 Q1	$543K	Buy	+28,799	New	+$670K	0.03%	481

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Profund Advisors's INBX Position: Q2 2024 in Review

Profund Advisors sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 31,335 shares — an estimated $1.1M sold.

Profund Advisors first reported a position in INBX in Q1 2023 and held it in 5 quarters. The position peaked at $1.1M in Q1 2024. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

Profund Advisors reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Profund Advisors sold 31,335 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $1.1M.
Profund Advisors first reported a position in Inhibrx, Inc. Common Stock in Q1 2023 and held it in 5 quarters.
Profund Advisors's Inhibrx, Inc. Common Stock position peaked at $1.1M in Q1 2024.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Profund Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.